T1	Condition 0 13	HIV infection
T2	Competing_trial 28 86	participation in previous or concurrent HIV vaccine trials
T3	Pregnancy_considerations 89 129	actating, pregnant or planning pregnancy
T4	Condition 131 156	renal function impairment
T5	Measurement 158 174	serum creatinine
T6	Value 175 185	>1.5 mg/dl
R1	Subsumes Arg1:T4 Arg2:T5	
T7	Condition 188 204	Fanconi syndrome
R2	Subsumes Arg1:T5 Arg2:T6	
R3	Has_value Arg1:T5 Arg2:T6	
T8	Measurement 215 235	liver function tests
T9	Value 206 214	abnormal
R4	Has_value Arg1:T8 Arg2:T9	
T10	Measurement 237 240	AST
T11	Measurement 241 244	ALT
T12	Value 245 253	> 43 U/L
*	OR T11 T10
T13	Scope 237 244	AST/ALT
R5	Subsumes Arg1:T8 Arg2:T13	
R6	Has_value Arg1:T13 Arg2:T12	
T14	Condition 256 269	liver disease
T15	Condition 271 286	viral hepatitis
T16	Condition 288 321	hepatitis B virus (HBV) infection
*	OR T14 T15 T16 T8
T17	Measurement 323 339	serum phosphorus
T18	Value 340 349	<2.2mg/dl
T19	Condition 351 363	osteoporosis
R7	Has_value Arg1:T17 Arg2:T18	
T20	Condition 371 382	sensitivity
T21	Drug 404 411	Truvada
R8	AND Arg1:T20 Arg2:T21	
T22	Procedure 430 457	immunosuppressive treatment
T23	Drug 467 491	systemic corticosteroids
R9	Subsumes Arg1:T22 Arg2:T23	
T24	Non-query-able 493 545	assumption of medication that interacts with Truvada
T25	Post-eligibility 548 610	high likelihood of poor adherence to PREP and clinic attendanc
T26	Non-query-able 613 771	any condition that in the opinion of the attending physician could endanger the health of the participant or render her unsuitable to participate in the trial
